Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Public ClinicalTrials.gov record NCT02102698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Tourette's Syndrome is a neurological disease characterized by motor and vocal tics. It has been hypothesized that abnormal interactions of dopamine with its receptors may cause the tics. The purpose of this study is to test the hypothesis that a drug (ecopipam) that selectively blocks dopamine D1/D5 receptors can reduce the frequency and severity of the tics.
Study identification
- NCT ID
- NCT02102698
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2014 (Actual)
- Primary completion
- Dec 2019 (Actual)
- Completion
- Dec 2019 (Actual)
- Last update posted
- May 22, 2026
2014 – 2019
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA | Los Angeles | California | 90024 | — |
| University of South Florida/Rothman Center for Neuropsychiatry | St. Petersburg | Florida | 33701 | — |
| Emory University School Of Medicine | Atlanta | Georgia | 30322 | — |
| University of Chicago Medical School | Chicago | Illinois | 60637 | — |
| Children's Mercy Kansas City | Kansas City | Kansas | 64108 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Overlook Hospital | Summit | New Jersey | 07902 | — |
| North Shore-Long Island Jewish Hosptial | Manhasset | New York | 11030 | — |
| Weill Cornell Medical School | New York | New York | 10065 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45228 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02102698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2026 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02102698 live on ClinicalTrials.gov.